Targeting the β-clamp in Helicobacter pylori with FDA-approved drugs reveals micromolar inhibition by diflunisal.
about
Targeting the β-clamp in Helicobacter pylori with FDA-approved drugs reveals micromolar inhibition by diflunisal.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Targeting the β-clamp in Helic ...... olar inhibition by diflunisal.
@en
Targeting the β-clamp in Helic ...... olar inhibition by diflunisal.
@nl
type
label
Targeting the β-clamp in Helic ...... olar inhibition by diflunisal.
@en
Targeting the β-clamp in Helic ...... olar inhibition by diflunisal.
@nl
prefLabel
Targeting the β-clamp in Helic ...... olar inhibition by diflunisal.
@en
Targeting the β-clamp in Helic ...... olar inhibition by diflunisal.
@nl
P2093
P2860
P356
P1433
P1476
Targeting the β-clamp in Helic ...... olar inhibition by diflunisal.
@en
P2093
Gunjan Gautam
Nilima Kumari
Preeti Pandey
Samudrala Gourinath
Vijay Verma
P2860
P304
P356
10.1002/1873-3468.12734
P407
P577
2017-06-28T00:00:00Z